Report cover image

Global Peptide APIs Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 189 Pages
SKU # APRC20553194

Description

Summary

According to APO Research, The global Peptide APIs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Peptide APIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Peptide APIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Peptide APIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Peptide APIs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Peptide APIs include Senn Chemicals, PolyPeptide, Pepscan, CordenPharma, BCN Peptides, Bachem and AmbioPharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Peptide APIs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Peptide APIs, also provides the sales of main regions and countries. Of the upcoming market potential for Peptide APIs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peptide APIs sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Peptide APIs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Peptide APIs sales, projected growth trends, production technology, application and end-user industry.

Peptide APIs Segment by Company

Senn Chemicals
PolyPeptide
Pepscan
CordenPharma
BCN Peptides
Bachem
AmbioPharm
Peptide APIs Segment by Type

Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Peptide APIs Segment by Application

Diabetes
Fertility
Obesity
Cancer
Other
Peptide APIs Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide APIs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Peptide APIs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide APIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Peptide APIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

189 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Peptide APIs Market Size, 2020 VS 2024 VS 2031
1.3 Global Peptide APIs Market Size Estimates and Forecasts (2020-2031)
1.4 Global Peptide APIs Sales Estimates and Forecasts (2020-2031)
1.5 Global Peptide APIs Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Peptide APIs Market Dynamics
2.1 Peptide APIs Industry Trends
2.2 Peptide APIs Industry Drivers
2.3 Peptide APIs Industry Opportunities and Challenges
2.4 Peptide APIs Industry Restraints
3 Peptide APIs Market by Manufacturers
3.1 Global Peptide APIs Revenue by Manufacturers (2020-2025)
3.2 Global Peptide APIs Sales by Manufacturers (2020-2025)
3.3 Global Peptide APIs Average Sales Price by Manufacturers (2020-2025)
3.4 Global Peptide APIs Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Peptide APIs Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Peptide APIs Manufacturers, Product Type & Application
3.7 Global Peptide APIs Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Peptide APIs Market CR5 and HHI
3.8.2 Global Top 5 and 10 Peptide APIs Players Market Share by Revenue in 2024
3.8.3 2024 Peptide APIs Tier 1, Tier 2, and Tier 3
4 Peptide APIs Market by Type
4.1 Peptide APIs Type Introduction
4.1.1 Liquid Phase Peptide Synthesis (LPPS)
4.1.2 Solid Phase Peptide Synthesis (SPPS)
4.2 Global Peptide APIs Sales by Type
4.2.1 Global Peptide APIs Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Peptide APIs Sales by Type (2020-2031)
4.2.3 Global Peptide APIs Sales Market Share by Type (2020-2031)
4.3 Global Peptide APIs Revenue by Type
4.3.1 Global Peptide APIs Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Peptide APIs Revenue by Type (2020-2031)
4.3.3 Global Peptide APIs Revenue Market Share by Type (2020-2031)
5 Peptide APIs Market by Application
5.1 Peptide APIs Application Introduction
5.1.1 Diabetes
5.1.2 Fertility
5.1.3 Obesity
5.1.4 Cancer
5.1.5 Other
5.2 Global Peptide APIs Sales by Application
5.2.1 Global Peptide APIs Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Peptide APIs Sales by Application (2020-2031)
5.2.3 Global Peptide APIs Sales Market Share by Application (2020-2031)
5.3 Global Peptide APIs Revenue by Application
5.3.1 Global Peptide APIs Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Peptide APIs Revenue by Application (2020-2031)
5.3.3 Global Peptide APIs Revenue Market Share by Application (2020-2031)
6 Global Peptide APIs Sales by Region
6.1 Global Peptide APIs Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Peptide APIs Sales by Region (2020-2031)
6.2.1 Global Peptide APIs Sales by Region (2020-2025)
6.2.2 Global Peptide APIs Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Peptide APIs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Peptide APIs Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Peptide APIs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Peptide APIs Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Peptide APIs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Peptide APIs Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Peptide APIs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Peptide APIs Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Peptide APIs Revenue by Region
7.1 Global Peptide APIs Revenue by Region
7.1.1 Global Peptide APIs Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Peptide APIs Revenue by Region (2020-2025)
7.1.3 Global Peptide APIs Revenue by Region (2026-2031)
7.1.4 Global Peptide APIs Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Peptide APIs Revenue (2020-2031)
7.2.2 North America Peptide APIs Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Peptide APIs Revenue (2020-2031)
7.3.2 Europe Peptide APIs Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Peptide APIs Revenue (2020-2031)
7.4.2 Asia-Pacific Peptide APIs Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Peptide APIs Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Peptide APIs Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Senn Chemicals
8.1.1 Senn Chemicals Comapny Information
8.1.2 Senn Chemicals Business Overview
8.1.3 Senn Chemicals Peptide APIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Senn Chemicals Peptide APIs Product Portfolio
8.1.5 Senn Chemicals Recent Developments
8.2 PolyPeptide
8.2.1 PolyPeptide Comapny Information
8.2.2 PolyPeptide Business Overview
8.2.3 PolyPeptide Peptide APIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 PolyPeptide Peptide APIs Product Portfolio
8.2.5 PolyPeptide Recent Developments
8.3 Pepscan
8.3.1 Pepscan Comapny Information
8.3.2 Pepscan Business Overview
8.3.3 Pepscan Peptide APIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Pepscan Peptide APIs Product Portfolio
8.3.5 Pepscan Recent Developments
8.4 CordenPharma
8.4.1 CordenPharma Comapny Information
8.4.2 CordenPharma Business Overview
8.4.3 CordenPharma Peptide APIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 CordenPharma Peptide APIs Product Portfolio
8.4.5 CordenPharma Recent Developments
8.5 BCN Peptides
8.5.1 BCN Peptides Comapny Information
8.5.2 BCN Peptides Business Overview
8.5.3 BCN Peptides Peptide APIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 BCN Peptides Peptide APIs Product Portfolio
8.5.5 BCN Peptides Recent Developments
8.6 Bachem
8.6.1 Bachem Comapny Information
8.6.2 Bachem Business Overview
8.6.3 Bachem Peptide APIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Bachem Peptide APIs Product Portfolio
8.6.5 Bachem Recent Developments
8.7 AmbioPharm
8.7.1 AmbioPharm Comapny Information
8.7.2 AmbioPharm Business Overview
8.7.3 AmbioPharm Peptide APIs Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 AmbioPharm Peptide APIs Product Portfolio
8.7.5 AmbioPharm Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Peptide APIs Value Chain Analysis
9.1.1 Peptide APIs Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Peptide APIs Production Mode & Process
9.2 Peptide APIs Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Peptide APIs Distributors
9.2.3 Peptide APIs Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.